Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Melnick

Showing results (301-310 of 322) with videos related to

Pageof 33
Sort By:
Nature Medicine|June 21, 2016
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemiaSheng Li, Francine E Garrett-Bakelman, Stephen S Chung, et al.
Blood Neoplasia|January 29, 2026
The LMO2-LDB1-TAL1 complex regulates transcription networks in acute myeloid leukemiaNicholas Dunham, Zhenjia Wang, Yaseswini Neelamraju, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Cancer Cell|May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformationWendy Béguelin, Relja Popovic, Matt Teater, et al.
Science Translational Medicine|March 9, 2022
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemiaLaura Barreyro, Avery M Sampson, Chiharu Ishikawa, et al.
The Journal of Clinical Investigation|April 5, 2022
Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphomaKatsuyoshi Takata, Lauren C Chong, Daisuke Ennishi, et al.
Biorxiv : the Preprint Server for Biology|December 22, 2025
Signaling induced biophysical disruption of repressed chromatin domains drives immune cell fateAlexia Martínez de Paz, Christopher R Chin, Mythili Ketavarapu, et al.
Cancer Cell|June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.
Nature Medicine|November 15, 2016
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingOlga A Guryanova, Kaitlyn Shank, Barbara Spitzer, et al.
Pageof 33

Showing results (301-310 of 322) with videos related to

Sort By:
Pageof 33
Nature Medicine|June 21, 2016
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemiaSheng Li, Francine E Garrett-Bakelman, Stephen S Chung, et al.
Blood Neoplasia|January 29, 2026
The LMO2-LDB1-TAL1 complex regulates transcription networks in acute myeloid leukemiaNicholas Dunham, Zhenjia Wang, Yaseswini Neelamraju, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Cancer Cell|May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformationWendy Béguelin, Relja Popovic, Matt Teater, et al.
Science Translational Medicine|March 9, 2022
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemiaLaura Barreyro, Avery M Sampson, Chiharu Ishikawa, et al.
The Journal of Clinical Investigation|April 5, 2022
Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphomaKatsuyoshi Takata, Lauren C Chong, Daisuke Ennishi, et al.
Biorxiv : the Preprint Server for Biology|December 22, 2025
Signaling induced biophysical disruption of repressed chromatin domains drives immune cell fateAlexia Martínez de Paz, Christopher R Chin, Mythili Ketavarapu, et al.
Cancer Cell|June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.
Nature Medicine|November 15, 2016
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingOlga A Guryanova, Kaitlyn Shank, Barbara Spitzer, et al.
Pageof 33